Meredith Schaum
Compliance Officer at Optimer Pharmaceuticals LLC
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Howard Marks | M | 77 |
University of Pennsylvania
| 24 years |
| Pamela S. Sears | M | - |
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | 22 years |
| Howard J. Dreskin | M | - |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | 17 years |
| Raphael Amit | M | 77 |
University of Pennsylvania
| 25 years |
| Robert Perez | M | 59 |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | 11 years |
| Thomas DesRosier | M | 69 |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | 11 years |
| Sherwood L. Gorbach | M | 89 |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | 19 years |
| Michael Tomsicek | M | 58 |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | 11 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Chang | M | 73 |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | 15 years |
| Henry McKinnell | M | 81 |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | 2 years |
| Pedro Lichtinger | M | 70 |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | 3 years |
| Kurt M. Hartman | M | 51 |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | 3 years |
| Bill Belleville | M | - |
University of Pennsylvania
| 2 years |
| David A. Cohen | M | - |
University of Pennsylvania
| 13 years |
| Reza Taleghani | M | 51 |
Villanova University
| 3 years |
| Peter M. Lamb | M | - |
University of Pennsylvania
| 3 years |
| Nehal Kamalapat Chopra | F | - |
University of Pennsylvania
| 4 years |
| César Orosco | M | - |
University of Pennsylvania
| 6 years |
| Tae Yamaura | F | - |
University of Pennsylvania
| 2 years |
| Mark Auerbach | M | 85 |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | 8 years |
| Robert J. Fioretti | M | - |
University of Pennsylvania
| 12 years |
| Matt E. Haggerty | M | - |
Villanova University
| 4 years |
| Sassan Alizadeh | M | - |
University of Pennsylvania
| 7 years |
| Simón Gaviria Muñoz | M | 43 |
University of Pennsylvania
| 4 years |
| Vijay Chattha | M | - |
University of Pennsylvania
| 5 years |
| Sean Evan Wright | M | 50 |
University of Pennsylvania
| 2 years |
| Robert Doebele | M | 53 |
University of Pennsylvania
| 4 years |
| Maja Sliwinski | F | - |
University of Pennsylvania
| 6 years |
| Thomas Pologruto | M | - |
University of Pennsylvania
| 4 years |
| Susan L. Nardone | F | - |
Villanova University
| 7 years |
| Nachi Gupta | M | - |
University of Pennsylvania
| 3 years |
| Chuck Myers | M | - |
University of Pennsylvania
| 5 years |
| Joseph Chang | M | 71 |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | 15 years |
| Salvatore Tirabassi | M | - |
University of Pennsylvania
| 3 years |
| Saam Farhang | M | - |
University of Pennsylvania
| 5 years |
| Charles Hebard | M | - |
University of Pennsylvania
| 11 years |
| David M. Hollond | M | - |
University of Pennsylvania
| 2 years |
| Robert Zerbe | M | 73 |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | 4 years |
| James S. Riepe | M | - |
University of Pennsylvania
| 4 years |
| Peter E. Grebow | M | 77 |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | 4 years |
| Anthony Altig | M | 68 |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | 6 years |
| Doug Asiello | M | 54 |
University of Pennsylvania
| 3 years |
| Vijai P. Mohan | M | - |
University of Pennsylvania
| 5 years |
| Mehul Trivedi | M | 53 |
University of Pennsylvania
| 9 years |
| Greg T. Pusch | M | - |
University of Pennsylvania
| 3 years |
| Aaron J. Perlis | M | - |
University of Pennsylvania
| 4 years |
| Jared Grusd | M | 49 |
University of Pennsylvania
| 4 years |
| Andrew McCormack | M | - |
University of Pennsylvania
| 4 years |
| Julienne R. Cassarino | F | - |
University of Pennsylvania
| 2 years |
| Marshall P. Levine | M | - |
University of Pennsylvania
| 2 years |
| Jennifer E. Leonard | F | - |
University of Pennsylvania
| 2 years |
| Scott Morenstein | M | 48 |
University of Pennsylvania
| 4 years |
| Kyle Rhoades | M | - |
University of Pennsylvania
| 4 years |
| Devesh Sharad Gandhi | M | - |
University of Pennsylvania
| 2 years |
| Ara Metupalle | M | - |
University of Pennsylvania
| 3 years |
| Edwin M OConnor | M | - |
University of Pennsylvania
| 3 years |
| Matthew Bender | M | - |
University of Pennsylvania
| 5 years |
| Sky Wilber | M | - |
University of Pennsylvania
| 3 years |
| Catherine LeGraw | F | - |
University of Pennsylvania
| 4 years |
| Michael Mandel | M | 49 |
University of Pennsylvania
| 4 years |
| Joseph Russell Magaro | M | 45 |
University of Pennsylvania
| 4 years |
| Andrew Jacobs | M | - |
University of Pennsylvania
| 4 years |
| Donald D. Pawelski | M | - |
University of Pennsylvania
| 4 years |
| Nadav Besner | M | 44 |
University of Pennsylvania
| 4 years |
| Michael S. Rome | M | - |
University of Pennsylvania
| 2 years |
| Peter Morgan Kash | M | 62 |
University of Pennsylvania
| 4 years |
| Sunitha Thomas | F | - |
University of Pennsylvania
| 2 years |
| Floyd H. Griffith | M | - |
University of Pennsylvania
| 4 years |
| Andrea Carr | F | - |
University of Pennsylvania
| 4 years |
| J. Diaz | M | 54 |
University of Pennsylvania
| 4 years |
| Orlando Mendoza | M | - |
University of Pennsylvania
| 1 years |
| Lloyd Sommers | M | - |
University of Pennsylvania
| 4 years |
| Kenton Rosenberry | M | - |
University of Pennsylvania
| 4 years |
| Seth M. Ginns | M | - |
University of Pennsylvania
| 4 years |
| Elizabeth Marie Bernstein | F | - |
University of Pennsylvania
| 4 years |
| Jennifer Preller | F | - |
Villanova University
| 4 years |
| Brian Kim | M | - |
University of Pennsylvania
| 4 years |
| Lily Ng | F | - |
University of Pennsylvania
| 4 years |
| Paul Kenneth Lisiak | M | 50 |
University of Pennsylvania
| 4 years |
| Mark C. Griffin | M | - |
University of Pennsylvania
| 2 years |
| Adam Zucker | M | 48 |
University of Pennsylvania
| 4 years |
| Jason S. Kahan | M | - |
University of Pennsylvania
| 4 years |
| Sandy Khaund | M | - |
University of Pennsylvania
| 2 years |
| Tom Hardin | M | - |
University of Pennsylvania
| 4 years |
| Hadley Harris | M | - |
University of Pennsylvania
| 4 years |
| Barbara Gordon Cohen | F | - |
University of Pennsylvania
| 2 years |
| Fatima Katarzyna Dickey | F | - |
University of Pennsylvania
| 2 years |
| Ashish Y. Shah | M | - |
University of Pennsylvania
| 4 years |
| LeAnne Stewart | F | 59 |
University of Pennsylvania
| 2 years |
| Rob Weber | M | - |
University of Pennsylvania
| 12 years |
| Daniel E. Weinbach | M | - |
University of Pennsylvania
| 2 years |
| Anthony Hoogs | M | - |
University of Pennsylvania
| 3 years |
| James Chris Quinn | M | - |
University of Pennsylvania
| 2 years |
| Alexander Efimovich Malakh | M | 60 |
University of Pennsylvania
| 2 years |
| Chris Sym | M | - |
University of Pennsylvania
| 4 years |
| Chia-Lun Wang | M | 48 |
University of Pennsylvania
| 4 years |
| Anthony Cambeiro | M | - |
University of Pennsylvania
| 4 years |
| Jonathan G. Marymor | M | - |
University of Pennsylvania
| 4 years |
| Craig Barney | M | - |
Villanova University
| 4 years |
| Adnan A. Aziz | M | - |
University of Pennsylvania
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Meredith Schaum
- Personal Network
